Not available
Quote | Pacira BioSciences Inc. (NASDAQ:PCRX)
Last: | $26.81 |
---|---|
Change Percent: | -0.54% |
Open: | $26.24 |
Close: | $26.81 |
High: | $27.09 |
Low: | $26.19 |
Volume: | 497,168 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | Pacira BioSciences Inc. (NASDAQ:PCRX)
2024-04-23 18:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 11:15:02 ET RBC Capital analyst issues UNDERPERFORM recommendation for PCRX on April 9, 2024 10:00AM ET. The previous analyst recommendation was Underperform. PCRX was trading at $28.44 at issue of the analyst recommendation. The overall analyst consensus : BU...
Message Board Posts | Pacira BioSciences Inc. (NASDAQ:PCRX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PCRX News Article - Pacira BioSciences Partners with The Invited Celebrity Classic - a | whytestocks | investorshangout | 04/20/2023 7:10:47 PM |
whytestocks: $PCRX News Article - Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manuf | whytestocks | investorshangout | 04/19/2023 4:35:50 PM |
whytestocks: $PCRX News Article - Pacira BioSciences Announces Positive Topline Data from Phase 3 St | whytestocks | investorshangout | 09/21/2022 6:40:48 PM |
wow, can you imagine if we will hit | stockstobuy | investorshub | 05/25/2022 3:05:06 AM |
Wow this company only issued a small note | stockstobuy | investorshub | 05/25/2022 2:36:18 AM |
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
2024-04-23 18:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 11:15:02 ET RBC Capital analyst issues UNDERPERFORM recommendation for PCRX on April 9, 2024 10:00AM ET. The previous analyst recommendation was Underperform. PCRX was trading at $28.44 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-04-09 11:15:02 ET Wedbush analyst issues BUY recommendation for PCRX on April 9, 2024 10:00AM ET. The previous analyst recommendation was Buy. PCRX was trading at $28.44 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst...